A roundup of where Lilly's experimental retatrutide stands in 2026. Specifics are in the full piece.
Recap by typeshit. Full story at Philstar Life.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
She describes her aim as simple education over trending protocols, citing more than 23 years as a certified sports nutritionist.
The Wall Street Journal looks at a growing number of teen boys using peptides, supplements and online advice as they try to improve themselves.
Loading…